Search Results - E. N. Bessonova
- Showing 1 - 12 results of 12
-
1
Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection by E. N. Bessonova
Published 2011-06-01Aim of investigation. To study efficacy and complications of antiviral therapy in patients with liver cirrhosis of HCV-etiology.Material and methods. Original study included 57 patients with liver cirrhosis of HCV-etiology of A and B classes by Child-Pugh, treated in Sverdlovsk regional center of he...
Get full text
Article -
2
SINGULARITY OF GROUP MANAGEMENT OF THE PATIENTS ON LIVER TRANSPLANTATION WAITING LIST by E. N. Bessonova, N. F. Klimusheva, Yu. A. Glazyrina
Published 2015-05-01.
Get full text
Article -
3
Urinary tract infections in patients with decompensated liver cirrhosis, listed for liver transplantation by P. D. Bessonov, I. V. Borzunov, E. N. Bessonova
Published 2018-08-01Aim of investigation. To study the urinary infection rate in patients with liver cirrhosis (LC) and indications for liver transplantation with assessment of etiologic spectrum and features of the progression of liver disease at development of this complication. Material and methods. The study includ...
Get full text
Article -
4
Predictive value of serum cytokine level in the assessment of complications after liver transplantation by A. Yu. Maksimova, E. N. Bessonova, V. V. Bazarnyy
Published 2021-03-01Introduction. One of the urgent tasks in modern transplantology is the search of biomarkers for predicting and early diagnosis of graft dysfunction.Objective. The study objective was to determine the biomarkers of liver graft dysfunction.Material and methods. We have examined 19 recipients who under...
Get full text
Article -
5
Research of <i>PNPLA3</i> I148M Gene Polymorphism in Patients with Non-Alcoholic Fatty Liver Disease, with Liver Cirrhosis and with Hepatocellular Carcinoma by V. V. Petkau, G. A. Tsaur, E. N. Bessonova, A. A. Karimova
Published 2023-11-01Aim: to determine the frequency of PNPLA3 rs738409 C>G gene polymorphism, leading to p.I148M substitution, in patients with non-alcoholic fatty liver disease (NAFLD), and to reveal the association between polymorphism and probable NAFLD outcomes: liver cirrhosis (LC) and hepatocellular carcin...
Get full text
Article -
6
THE EXPERIENCE OF WAITING LIST MANAGEMENT FOR LIVER TRANSPLANTATION IN EKATERINBURG by E. N. Bessonova, I. A. Kornilova, O. A. Stroganova, Y. A. Glazyrina, N. F. Klimusheva
Published 2011-12-01Gaining the experience of liver transplantation waiting list formation is the important condition of transplant cen- ter successful work. In the era of transplant organ shortage careful medical examination of the patient before the operation and detection of unfavorable facts and transplantation con...
Get full text
Article -
7
Role of portocaval shunts in development of complications after liver transplantation by D. L. Tsoy, M. I. Prudkov, O. G. Orlov, E. N. Bessonova, I. G. Leshchenko, L. V. Kardopoltsev, A. N. Ageev, S. I. Solodushkin
Published 2022-06-01Rationale. Portal blood flow is a key component in the viability of the liver transplant.Portocaval shunts formed on the background of the liver cirrhosis before transplantation can cause portal vein steal syndrome, with subsequent development of ischemic necrosis of the graft.To date, the tactics o...
Get full text
Article -
8
Diagnostic and Prognostic Value of Hyperammonemia in Patients with Liver Cirrhosis, Hepatic Encephalopathy, and Sarcopenia (Experts’ Agreement) by M. Yu. Nadinskaia, M. V. Maevskaya, I. G. Bakulin, E. N. Bessonova, A. O. Bueverov, M. S. Zharkova, S. V. Okovityi, A. S. Ostrovskaya, K. A. Gulyaeva, V. T. Ivashkin
Published 2024-03-01Introduction. In cirrhotic patients, hyperammonemia develops due to impaired ammonia detoxification and portosystemic blood shunting and is most commonly associated with hepatic encephalopathy and sarcopenia. Currently, there are questions regarding the diagnosis of hyperammonemia and the effect of...
Get full text
Article -
9
Screening and Early Diagnosis of Hepatocellular Cancer and Optimization of Diagnostic Imaging Techniques: A Review and Conclusion of the Expert Panel by V. V. Breder, R. B. Alikhanov, S. S. Bagnenko, E. N. Bessonova, V. A. Isakov, N. E. Kudashkin, B. M. Medvedeva, A. V. Mishchenko, M. S. Novruzbekov, V. S. Rudakov
Published 2023-02-01Аim: to describe modern approaches for screening and early diagnosis of hepatocellular carcinoma (HCC).Key points. Screening for HCC in high-risk groups (cirrhosis of any etiology, patients with chronic viral hepatitis B and patients with F3 liver fibrosis) should be organized as regular (every 6 mo...
Get full text
Article -
10
Recommendations for the prevention and treatment of hepatitis B and C infection in patients on the waiting list for liver transplantation and in liver transplant recipients by M. Sh. Khubutiya, S. E. Voskanyan, V. E. Syutkin, V. P. Chulanov, M. S. Novruzbekov, V. D. Pasechnikov, V. L. Korobka, O. O. Rummo, E. N. Bessonova, S. F. Bagnenko, D. I. Abdulganiyeva
Published 2020-09-01.
Get full text
Article -
11
Liver transplantation in Yekaterinburg: the first experience by E. N. Bessonova, O. G. Orlov, S. Yu. Alferov, M. I. Prudkov, N. F. Klimusheva, B. V. Fadin, A. L. Levit, D. A. Levit, I. G. Leshchenko, Yu. I. Petrishchev, I. Yu. Serebryakov, S. D. Chernyshov
Published 2018-08-01Today orthotopic liver transplantation is the only radical treatment of patients with end- stage chronic diffuse liver diseases. In Russia, liver transplantation is currently made in 8 transplantation centers of Moscow, Saint Petersburg, Yekaterinburg, Belgorod, Nizhni Novgorod, and Samara. The pape...
Get full text
Article -
12
Correction of Thrombocytopenia before Elective Surgery / Invasive Procedures in Patients with Liver Cirrhosis (Experts’ Agreement) by M. V. Maevskaya, M. Yu. Nadinskaia, E. N. Bessonova, N. I. Geyvandova, M. S. Zharkova, E. A. Kitsenko, N. V. Korochanskaya, I. A. Kurkina, A. L. Melikyan, V. G. Morozov, Yu. V. Khoronko, T. A. Deeva, K. A. Gulyaeva, V. T. Ivashkin
Published 2024-08-01Introduction. As a result of portal hypertension (sequestration of platelets in an enlarged spleen) and liver failure (decreased production of thrombopoietin in the liver) in liver cirrhosis, thrombocytopenia develops, which is associated with the risk of periprocedural/perioperative bleeding compli...
Get full text
Article